NEDA cautions that for people with active eating disorders or a history of disordered eating, these drugs can be harmful when not used for their intended purpose, when inadequately monitored or monitored by clinicians without eating disorder expertise, or when used for weight loss motivated by weight stigma. That doesnt mean GLP-1s are automatically off the table, but it does mean that this decision warrants extra care, specialist input, and close monitoring throughout
500 Million AFU
However, it also suppressed my appetite a lot more and caused several hypoglycemia events
Stahl EP, Dhindsa DS, Lee SK, Sandesara PB, Chalasani NP, Sperling LS (2019) Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review
Start with a lower dose than patients reported compounded drug dose and titrate up slowly, Basina said